Indication
Klinefelter's syndrome
Klinefelter's syndrome is a sex-chromosome disorder in phenotypic males caused by the presence of one or more supernumerary X chromosomes, most commonly manifesting as a 47,XXY karyotype. Read more about Klinefelter's syndrome
96 drugs 62 manufacturers
Drugs that treat it
Common Klinefelter's syndrome therapies.
TESTONE CIK (testosterone cypionate)
TESTOPEL (testosterone)
TESTIM (testosterone)
STRIANT (testosterone)
TESTOSTERONE
TESTOSTERONE
TESTOSTERONE CYPIONATE
TESTOSTERONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonKlinefelter's syndrome is a sex-chromosome disorder in phenotypic males caused by the presence of one or more supernumerary X chromosomes, most commonly manifesting as a 47,XXY karyotype.
The condition primarily impacts the endocrine and male reproductive systems, characterized pathologically by progressive testicular fibrosis, seminiferous tubule hyalinization, and primary hypogonadism.
Defining clinical features include microorchidism, low testosterone production, hypergonadotropic hypogonadism, azoospermia, and consequent infertility.
Additional manifestations frequently include tall stature with eunuchoid proportions, gynecomastia, reduced body and facial hair, decreased muscle mass, and variable neurocognitive or metabolic complications.
- medlineplus.gov
Klinefelter's syndrome is a sex-chromosome disorder in phenotypic males caused by the presence of one or more supernumerary X chromosomes, most commonly manifesting as a 47,XXY karyotype The condition primarily impacts the endocrine and male reproductive systems, characterized pathologically by progressive testicular fibrosis, seminiferous tubule hyalinization, and primary hypogonadism Defining clinical features include microorchidism, low testosterone production, hypergonadotropic hypogonadism,...
- nih.gov
Klinefelter's syndrome is a sex-chromosome disorder in phenotypic males caused by the presence of one or more supernumerary X chromosomes, most commonly manifesting as a 47,XXY karyotype The condition primarily impacts the endocrine and male reproductive systems, characterized pathologically by progressive testicular fibrosis, seminiferous tubule hyalinization, and primary hypogonadism Defining clinical features include microorchidism, low testosterone production, hypergonadotropic hypogonadism,...
- medlineplus.gov
Additional manifestations frequently include tall stature with eunuchoid proportions, gynecomastia, reduced body and facial hair, decreased muscle mass, and variable neurocognitive or metabolic complications
Personalize your experience
Follow Klinefelter's syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.